Based on the results from our study as well as many others, we hypothesized that, at a relatively low expression level, the upregulation of CBS/H2S triggers a series of downstream reactions that promote the growth and dissemination of CRC cells, which override the tumor-suppressing effect stemming from the downregulation of CD44. The gene discussed is CBS; the disease is colorectal carcinoma.